Navigation Links
vProtect(TM) Luminal Shield Stabilizes Vulnerable Plaque
Date:6/1/2009

study methodology can be found in a case study published recently in Nature Reviews Cardiology (vol. 6, May 2009).

The follow-up exam indicated that the self-expanding vProtect(TM) Luminal Shield had stabilized the vulnerable lesion while gently expanding over time. Imaging studies revealed that the residual stenosis in the area of the lesion improved from 30% to just 5% (measured by Quantitative Angiography). The Shield was covered by a thin layer of healthy tissue with an average thickness of 80 - 110 microns. "These results are comparable to what is seen with drug eluting stents in terms of thickness--we did not see a significant hyperplastic injury response," commented cardiac pathologist Gary Tearney, MD, PhD. Dr. Tearney, an Associate Professor of Pathology at Harvard University and the Wellman Center for Photomedicine, went on to explain that "The Shield appears to be perfectly designed for just this type of lesion--since it's self-expanding, there is less chance of rupturing the plaque."

Prescient Medical views the SECRITT I trial as a significant step toward achieving its mission of reducing deaths from heart attacks. According to Prescient CEO Patricia Scheller, "In the future, we hope that the Shield will be used to stabilize these soft, rupture-prone lesions without causing excessive injury to the vessel wall like traditional balloon-expandable stents. We are very encouraged by the healthy endothelial tissue coverage and reduced stenosis demonstrated in this patient."

About Prescient Medical, Inc.

Prescient Medical, Inc. is a privately held medical device company dedicated to reducing deaths from heart attacks, the leading cause of death in much of the world. For more information, please visit our website at www.prescientmedical.com or call +1-866-376-0500.


'/>"/>
SOURCE Prescient Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Prescient Medical Achieves Milestones in Clinical Studies of vProtect(TM) Luminal Shield
2. Patient Receives vProtect(TM) Luminal Shield in First-Ever Vulnerable Plaque Clinical Trial
3. Prescient Medical, Inc. Achieves Successful Clinical Debut of vProtect(TM) Luminal Shield
4. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
5. Doctors Urge Precaution to Shield Against Swine Flu
6. NanoVibronix Receives Wound Healing Indications in Europe for its PainShield(TM) Device
7. Blue Cross Blue Shield Of Michigan Battles Sluggish Economy With Diverse Product Lineup
8. Seal Shield Launches Worlds First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control
9. Medivations Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimers Disease Patients, Resulting in Reduced Caregiver Distress
10. Galderma Announces Interim Data Relating to Sequential Treatment Regimen of Clobex(R) Spray Followed by Vectical(TM) Ointment in Managing Plaque Psoriasis
11. FDA Advisory Committee Unanimously Recommends Approval of Ustekinumab for Treatment of Moderate to Severe Plaque Psoriasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)...  Decision Resources Group finds that the laparoscopic device ... will increase to a value of over $4.3 billion ... in the large direct energy device market. In particular, ... due to the advantages they offer and as new ... Decision Resources Group,s coverage of the U.S. laparoscopic device ...
(Date:12/19/2014)... Since last month,s FBI shutdown of online ... the leading online black market for illegal drugs - ... offering of drugs and other illegal items.  New numbers ... succeed in lowering the numbers of drugs and illegal ... in August. But some new sites that have emerged ...
(Date:12/17/2014)... AMSTERDAM and SAN DIEGO , ... PHG ; AEX: PHIA) and Volcano Corporation (NASDAQ: ... and measurement solutions for cardiovascular applications, today announced that they ... agreement, Philips will commence a tender offer to acquire all ... 18.00 per share, or a total equity purchase price of ...
Breaking Medicine Technology:U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 2U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 3Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 2Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 2Philips to acquire Volcano to expand global leadership position in image-guided therapy market 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 4Philips to acquire Volcano to expand global leadership position in image-guided therapy market 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 6Philips to acquire Volcano to expand global leadership position in image-guided therapy market 7Philips to acquire Volcano to expand global leadership position in image-guided therapy market 8
... The research team at the,Nemours Center for ... Nemours Biomedical Research at the Alfred I. duPont ... prostate specific,membrane antigen (PSMA), abundantly present in cancer ... contributory role in the progression,of cancer to an ...
... Once-daily TMC278, the third anti-HIV compound to be developed in ... ... YARDLEY, Pa., July 17 Tibotec Pharmaceuticals Ltd.,announced today that ... reverse transcriptase inhibitor (NNRTI),in treatment-naive adults with HIV-1, are now ...
Cached Medicine Technology:Nemours Center for Childhood Cancer Research Team at the Alfred I. duPont Hospital for Children Identifies the Function of a Biomarker Present in Prostate Cancer Cells: New Insight into Therapeutic Benefit for Patients with Advanced Prostate Cancer 2Nemours Center for Childhood Cancer Research Team at the Alfred I. duPont Hospital for Children Identifies the Function of a Biomarker Present in Prostate Cancer Cells: New Insight into Therapeutic Benefit for Patients with Advanced Prostate Cancer 3Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV 2Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV 3
(Date:12/21/2014)... Over the past 39 years, NES Health has ... departments across the nation, from quality of medical care ... an innovative suite of tools, systems, and programs that ... patient experience. , NES Health, a leading national ... for hospitals, announced the development and launch of its ...
(Date:12/21/2014)... Downey, CA (PRWEB) December 21, 2014 The ... toy drive in the Santa Ana and Whittier offices. The ... help brighten the lives of patients and their families during ... to reach out to approximately 70 children between both offices. ... With the help of Target’s community service team, store managers ...
(Date:12/20/2014)... Weddingshe.com has recently announced its new ... promotion of special occasion dresses for the coming new ... special occasion dresses for global women. Now, all the ... up to 80% off. Among the new items, the ... 16 Dress) is very popular. What’s more, Weddingshe.com also ...
(Date:12/20/2014)... (HealthDay News) -- The holidays can be anything but ... fresh trees, scented candles and other allergy triggers. ... that have been packed away in dank basements or ... asthma patients," Dr. Rachna Shah, an affiliate faculty member ... in Loyola news release. Shah, who is also ...
(Date:12/20/2014)... 20, 2014 Atore, Inc, (San Francisco, ... launched first birthday focused portal on December 17th, 2014. ... launched in both US and Japan. , MERRY BIRTHDAY ... http://merrybirthday.net/message/ , MERRY BIRTHDAY MESSAGE is part ... the world. , Features, Choose from thousands of stock ...
Breaking Medicine News(10 mins):Health News:NES Health Launches Stipend Program for Emergency Physicians in Training to Financially Assist Emergency Department Doctors While They Learn 2Health News:Tons of New-in Winter Sweet 16 Dresses from Weddingshe Online Now 2Health News:Holiday Trimmings Can Trigger Allergies 2Health News:Atore, Inc. Releasing the First Birthday Portal 2
... Provides Patient Tips For Safe Plastic Surgery Procedures, ... Donda West,rapper Kanye West,s mother, raised questions about the ... death are still emerging,and include concerns over her physician,s ... in a lengthy surgery. "Patients should,be reassured that Donda ...
... & Bar, other partners and donors share in ... the new National,Pediatric Brain Tumor Consortium headquarters, ... in,translational research for exceptional patient care, MEMPHIS, ... and Chili,s Grill & Bar(R) celebrated the national,grand ...
... Following is a statement,by Linda A. Suydam, ... regarding today,s FDA public meeting seeking comments,on a ... of our member companies, CHPA was pleased to ... of expanded consumer,access to medicines. As the leading ...
... Date, WASHINGTON, Nov. 14 The following was,released by the National Kidney Foundation of ... Ball will feature entertainment by the ... of the ... community leaders. Guests will also enjoy cocktails, dinner, ...
... lessening of the drug may ease addiction, research suggests , ... of gradually decreasing levels of nicotine over a number of ... finds. , The study, conducted by researchers at the University ... Medical Center, included 20 adult smokers. They puffed on their ...
... OSS, Netherlands, Nov. 14 Asenapine -- a ... was shown to be,effective and well-tolerated in patients ... in the current issue of the Journal,of Clinical ... Psychiatric Association,s (APA) annual meeting and at the ...
Cached Medicine News:Health News:Guide to Minimizing Your Plastic Surgery Risks 2Health News:St. Jude Celebrates Next Frontier of Finding Cures With Grand Opening of Chili's Care Center 2Health News:St. Jude Celebrates Next Frontier of Finding Cures With Grand Opening of Chili's Care Center 3Health News:St. Jude Celebrates Next Frontier of Finding Cures With Grand Opening of Chili's Care Center 4Health News:Statement From the Consumer Healthcare Products Association on Proposed New 'Third Class' of Medicines 2Health News:Nicotine-Reduced Cigarettes Could Boost Quitting 2Health News:Study Shows Organon's Asenapine Demonstrates Efficacy and Tolerability in Treating Acute Schizophrenia 2Health News:Study Shows Organon's Asenapine Demonstrates Efficacy and Tolerability in Treating Acute Schizophrenia 3Health News:Study Shows Organon's Asenapine Demonstrates Efficacy and Tolerability in Treating Acute Schizophrenia 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: